Catalyst Pharmaceuticals Inc (CPRX)

02:12 AM

Will Catalyst Pharmaceuticals Inc. stock split again soonJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com

02:12 AM

01:31 AM

Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden - GlobeNewswire Inc.

01:31 AM

01:17 AM

What risks investors should watch in Catalyst Pharmaceuticals Inc. stockMarket Growth Review & Free Reliable Trade Execution Plans - newser.com

01:17 AM

01:15 AM

Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com

01:15 AM

Nov 03, 2025

Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Historical Comparison & Risk Controlled Daily Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Why global investors buy Catalyst Pharmaceuticals Inc. (CN2) stockWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - The Manila Times

Nov 03, 2025

Nov 03, 2025

Momentum divergence signals in Catalyst Pharmaceuticals Inc. chartJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weakness2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Quarterly Portfolio Report & Expert Curated Trade Setups - newser.com

Nov 03, 2025

Nov 03, 2025

Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance

Nov 03, 2025

Nov 03, 2025

Can Catalyst Pharmaceuticals Inc. hit a new high this monthEarnings Overview Report & High Return Stock Watch Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

What analyst consensus says on Catalyst Pharmaceuticals Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat

Nov 03, 2025

Nov 03, 2025

Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesWeekly Loss Report & Consistent Return Investment Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 02, 2025

Nov 02, 2025

Catalyst Pharmaceuticals Inc. recovery potential after sell offWeekly Trade Report & Entry Point Confirmation Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025

Nov 01, 2025

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Moody Aldrich Partners LLC - MarketBeat

Nov 01, 2025

Oct 31, 2025

Will Catalyst Pharmaceuticals Inc. (CN2) stock sustain uptrend momentumBuy Signal & Community Verified Watchlist Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Is Catalyst Pharmaceuticals Inc. stock bottoming outWeekly Stock Recap & Low Risk Entry Point Guides - newser.com

Oct 31, 2025

Oct 31, 2025

Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsAnalyst Downgrade & Stock Portfolio Risk Control - newser.com

Oct 31, 2025

Oct 31, 2025

How rising interest rates impact Catalyst Pharmaceuticals Inc. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com

Oct 31, 2025

Oct 30, 2025

Yorktown Management & Research Co Inc Trims Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Oct 30, 2025

Oct 29, 2025

Catalyst Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 29, 2025

Oct 29, 2025

Earnings Preview: Catalyst Pharmaceutical (CPRX) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 29, 2025